Last reviewed · How we verify
Lower limb spasticity
Approved treatments
- Nuceiva · GlaxoSmithKline K.K.
Nuceiva works by blocking the release of acetylcholine, a neurotransmitter that transmits signals from nerve cells to muscles, thereby reducing muscle spasms and contractions.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Lower limb spasticity patent landscape — cliff calendar, originator estates, attackable patents
- Lower limb spasticity treatment landscape brief
- Lower limb spasticity treatment updates RSS
Frequently asked questions about Lower limb spasticity
What drugs treat Lower limb spasticity?
Tracked treatments include Nuceiva.
What is the treatment for Lower limb spasticity?
Standard treatment for Lower limb spasticity includes Nuceiva. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Lower limb spasticity patent cliff · Lower limb spasticity CI report
- Treatment: Nuceiva · GlaxoSmithKline K.K.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing